Focus

SK Bioscience submits request for inclusion of SKYCovione on WHO emergency use listing

08 Sep 2022 01:39pm
SKYCovione, is a recombinant-protein vaccine based on novel two-component nanoparticles that can maximize immune efficiency. - Photo: International Vaccine Institute
SKYCovione, is a recombinant-protein vaccine based on novel two-component nanoparticles that can maximize immune efficiency. - Photo: International Vaccine Institute
SEOUL - South Korean pharmaceutical SK Bioscience Co. said Thursday it has submitted a request with the World Health Organisation (WHO) to have its COVID-19 vaccine SKYCovione be part of the agency's emergency use listing (EUL).

The EUL qualifies unlicensed vaccines, therapeutics and in vitro diagnostics to be made available to people affected by a public health emergency. The listing is essential for companies to participate in bids by international health agencies.

The South Korean company submitted a separate request for conditional usage approval of SKYCovione with the European Medicines Agency in July, Yonhap news agency reported.

SK Bioscience CEO, Ahn Jae Yong, said the company will take the lead in responding to the COVID-19 pandemic by promptly obtaining approval from global health regulatory agencies.

South Korea's first homegrown vaccine, SKYCovione, is a recombinant-protein vaccine based on novel two-component nanoparticles that can maximize immune efficiency. It made its market debut in South Korea last Friday. - BERNAMA
Related Articles:


SK Bioscience
SKYCovione
World Health Organisation
emergency use listing
More Like This
Photo for illustrative purposes only - Canva
Photo for illustrative purposes only - Canva
World One dead, one injured in Australian helicopter crash
The two men were travelling in an US-registered Super Puma helicopter when it crashed shortly before midday.
Photo for illustration purposes only.
Photo for illustration purposes only.
World Singapore hangs third drug trafficker in a week
The hanging at Changi prison followed the Nov 15 execution of two men -- a 39-year-old Malaysian and a 53-year-old Singaporean -- also for drug trafficking.
A chimpanzee is pictured at the Pridadomus recovering centre in Villena, near Alicante. AFP FILE PIX
A chimpanzee is pictured at the Pridadomus recovering centre in Villena, near Alicante. AFP FILE PIX
World Chimps are upping their tool game, says study
"Planet of the Apes" may have been onto something.
US President-elect Donald Trump is handing top roles in his future administration to a mix of allies, provocateurs and a few relatively conventional figures. - (Photo by various sources / AFP)
US President-elect Donald Trump is handing top roles in his future administration to a mix of allies, provocateurs and a few relatively conventional figures. - (Photo by various sources / AFP)
World Trump's top team: Firebrands and stalwarts
WASHINGTON - US President-elect Donald Trump is handing top roles in his future administration to a mix of allies, provocateurs and a few relatively conventional figures. Most positions require Senate approval, which brings added scrutiny. Here is who Trump has chosen so far: - Health Secretary:...